Sally Clive

Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre, randomised, controlled, phase 3 trial

John Bridgewater, S. Pugh, Tom Maishman et al. · The Lancet Oncology · 2020 · 239 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

A Phase I/II, Multiple-Dose, Dose-Escalation Study of Siltuximab, an Anti-Interleukin-6 Monoclonal Antibody, in Patients with Advanced Solid Tumors

Eric Angevin, Josep Tabernero, Elena Élez et al. · Clinical Cancer Research · 2014 · 206 citations

Pharmacy, Oncology, Pharmacology +17

Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Quality of Life and Cancer Control Among Older and Frail Patients With Advanced Gastroesophageal Cancer

Peter S Hall, Daniel Swinson, David A. Cairns et al. · JAMA Oncology · 2021 · 191 citations · Full text

Medicine, Geriatric Medicine, Oncology +14

Miltefosine as a topical treatment for cutaneous metastases in breast carcinoma

Sally Clive, J. Gardiner, Renaud Léonard · Cancer Chemotherapy and Pharmacology · 1999 · 81 citations

Medicine, Oncology, Pharmacology +16

Randomized phase 2 study of pegylated SN‐38 (EZN‐2208) or irinotecan plus cetuximab in patients with advanced colorectal cancer

Christopher R. Garrett, Tanios Bekaii‐Saab, Theresa Ryan et al. · Cancer · 2013 · 60 citations

Medicine, Oncology, Pharmacology +16